The Macerich Company MAC · NYSE
$22.54 -1.83% (-$0.42)
Summary
35 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 21 USD is left as free cash.
What to watch
- The company made a loss over the last 12 months.
- Operating profit does not even cover the interest on its debt.
- The share price is above the Bulios Fair Price.
- It missed profit estimates 5 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 5.3% a year over 5 years. Over the last 3 years it grew by 5.7% a year. For the next fiscal year analysts expect revenue to fall by 2.4%.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $169.5M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 22.9 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, at risk- Yield
- 2.96%
You receive $0.68 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Neutral- Buy 15
- Hold 16
- Sell 4
Today's price within the analysts' price targets
The average target of $26 is 15% above today's price. 43% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Real Estate, Other 64%
- Management Service 36%
By region
The company reports no revenue by region.
Real Estate, Other brings in 64% of revenue.
Segments in detail